Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$7.2M
-4.0% from 2023
Prescriptions
984
$7,279.90 per claim
Patients
234
154 prescribers
Total spending, 2024
$7.2M
$30,612.92 per patient
Medicare prescription drug plans paid $7.2M for Abraxane in 2024, for 984 prescriptions and refills to 234 patients (down 4.0% from 2023). The average cost per claim was $7,279.90.
California had the highest Medicare cost for Abraxane in 2024: $1.7M for 212 claims, followed by Florida ($1.1M).
Nader Javadi, hematology-oncology in Calabasas, CA, had the highest Medicare cost for Abraxane in 2024: 45 claims costing $279K.
Abraxane is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as BMS-Abraxis Bio.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Nader Javadi Calabasas, CA | Hematology-Oncology | 45 | 11 | $279K |
| Yasir Alhassani Temple Terrace, FL | Hematology-Oncology | 17 | Under 11 | $229K |
| Swetha S Yadav |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 135 | 810 | 220 | $6.2M |
| 2023 | 143 | 932 | 249 | $7.5M |
| 2024 | 154 | 984 | 234 | $7.2M |
Spending by manufacturer as listed in the spending data
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 17 |
| Under 11 |
| $221K |
| Amir A Rasheed Baytown, TX | Hematology-Oncology | 22 | Under 11 | $206K |
| Ravi K Patel Stuart, FL | Hematology-Oncology | 28 | Under 11 | $181K |
| Antoine E Chahine Canfield, OH | Medical Oncology | 53 | Under 11 | $172K |
| Aasim S Sehbai Anniston, AL | Medical Oncology | 19 | Under 11 | $162K |
| Satish A Shah Gettysburg, PA | Hematology-Oncology | 39 | Under 11 | $149K |
| Krisztina I Larson Burbank, CA | Hematology-Oncology | 16 | Under 11 | $147K |
| Kirtan N Koticha Shreveport, LA | Hematology-Oncology | 20 | Under 11 | $142K |
| Mihran Shirinian Glendale, CA | Hematology-Oncology | 34 | Under 11 | $132K |
| Melvin P Palalay Honolulu, HI | Hematology-Oncology | 17 | Under 11 | $120K |
| John G Knecht III Webster, TX | Hematology-Oncology | 18 | Under 11 | $118K |
| Santosh M Nair Orange City, FL | Hematology-Oncology | 18 | Under 11 | $116K |
| Manish Dhawan Minden, LA | Hematology-Oncology | 11 | Under 11 | $112K |
| Samuel D Bailey Hazard, KY | Hematology-Oncology | 11 | Under 11 | $106K |
| Eddie Thara Downey, CA | Hematology-Oncology | 13 | Under 11 | $102K |
| Jeana Drugac Denville, NJ | Nurse Practitioner | 14 | Under 11 | $100K |
| Vinicio Hernandez Orlando, FL | Medical Oncology | 13 | Under 11 | $94K |
| Kee Y Shum Flushing, NY | Internal Medicine | 12 | Under 11 | $76K |
| Omar Al Ustwani Vineland, NJ | Hematology-Oncology | 11 | Under 11 | $66K |
| Carlos M Tejeda Fajardo, PR | Hematology-Oncology | 13 | Under 11 | $62K |
| Arjun Iyengar New York, NY | Hematology-Oncology | 14 | Under 11 | $61K |
| Tina A Khair Gettysburg, PA | Hematology-Oncology | 18 | Under 11 | $57K |
| Suneeta Pinnamaneni Leesburg, FL | Hematology-Oncology | 12 | Under 11 | $53K |
| Manufacturer | Claims | Spending |
|---|---|---|
| BMS-Abraxis Bio BMY | 984 | $7.2M |